Lv11
20 积分 2024-10-31 加入
703P Efficacy and safety of lurbinectedin in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter, retrospective real-world study
7小时前
求助中
Real-world evidence for immunotherapy in the first line setting in small cell lung cancer
8小时前
已完结
A STAT3–STING–IFN axis controls the metastatic spread of small cell lung cancer
1个月前
已完结
5-HT orchestrates Histone Serotonylation and Citrullination to Drive Neutrophil Extracellular Traps and Liver Metastasis
1个月前
已完结
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
3个月前
已完结
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
3个月前
已完结
OA16.04 Preliminary Results from a FIH Study of GQ1005, A Novel HER2-ADC, in Patients with Advanced HER2-Expressing Solid Tumors and HER2-Mutated NSCLC
3个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
3个月前
已完结
Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression
5个月前
已完结
Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies
5个月前
已完结
皖公网安备34019202002308
